headache relief

Generic: acetaminophen-aspirin-caffeine

Labeler: target corporation
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name headache relief
Generic Name acetaminophen-aspirin-caffeine
Labeler target corporation
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

acetaminophen 250 mg/1, aspirin 250 mg/1, caffeine 65 mg/1

Manufacturer
TARGET CORPORATION

Identifiers & Regulatory

Product NDC 11673-070
Product ID 11673-070_21584bc6-a28f-14ee-e063-6394a90a5ce6
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2019-10-04

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673070
Hyphenated Format 11673-070

Supplemental Identifiers

RxCUI
308297
UNII
362O9ITL9D R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name headache relief (source: ndc)
Generic Name acetaminophen-aspirin-caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 100 TABLET, COATED in 1 BOTTLE (11673-070-01)
  • 275 TABLET, COATED in 1 BOTTLE (11673-070-72)
source: ndc

Packages (2)

11673-070-01 100 TABLET, COATED in 1 BOTTLE (11673-070-01) 11673-070-72 275 TABLET, COATED in 1 BOTTLE (11673-070-72)

Ingredients (3)

acetaminophen (250 mg/1) aspirin (250 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

HEADACHE RELIEF ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "21584bc6-a28f-14ee-e063-6394a90a5ce6", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["8e953cef-135e-f1aa-e053-2995a90aaa8b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE (11673-070-01)", "package_ndc": "11673-070-01", "marketing_start_date": "20200204"}, {"sample": false, "description": "275 TABLET, COATED in 1 BOTTLE (11673-070-72)", "package_ndc": "11673-070-72", "marketing_start_date": "20200204"}], "brand_name": "HEADACHE RELIEF", "product_id": "11673-070_21584bc6-a28f-14ee-e063-6394a90a5ce6", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "11673-070", "generic_name": "ACETAMINOPHEN-ASPIRIN-CAFFEINE", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "HEADACHE RELIEF", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20191004", "listing_expiration_date": "20261231"}